Impact of blood-brain barrier disruption on newly diagnosed neuromyelitis optica spectrum disorder symptoms and prognosis

被引:13
|
作者
Liang, Shuolin [1 ]
Qin, Qiuhong [2 ]
Tang, Yulan [1 ]
Liao, Weijing [3 ]
Yang, Yi [1 ]
He, Jinrong [1 ]
Li, Liangsheng [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Dept Histol, Nanning 530021, Peoples R China
[3] Guangxi Med Univ, Affiliated Wuming Hosp, Dept Neurol, Nanning 530199, Peoples R China
基金
中国国家自然科学基金;
关键词
Blood-brain barrier (BBB); neuromyelitis optic spectrum disorders; newly diagnosis; optic neuritis; albumin quotient (qalb); T-CELLS; MULTIPLE-SCLEROSIS;
D O I
10.21037/apm.2019.12.12
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Blood-brain barrier (BBB) disruption and ensuing immune activation are central to the pathogenesis of central nervous system (CNS) inflammatory diseases. However, the influence of BBB permeability on the clinical signs and prognosis of newly diagnosed neuromyelitis optica spectrum disorder (NMOSD) has not been examined. We investigate the relationships between BBB permeability as showed by the albumin quotient (qalb) and clinical features of NMOSD. Methods: Demographic and clinical data of 46 patients, including peripheral blood (PB) measures (serum albumin concentration and total leukocyte, neutrophil, total lymphocyte, CD4+ T cell, and CD8+ T cell counts, complement C3 and C4 concentrations, AQP4-IgG titer),autoimmune antibody titers (ANA/SSA/SSB/ Ro-52), and cerebrospinal fluid (CSF) parameters (total leukocyte count, total protein and albumin concentrations, AQP4-IgG titer), were compared between qalb(BBB permeability) increased and normal groups. Complete measures were not obtained from 9 patients, but all other measures were included in the analysis. Results: According to the calculated qalb, 15 patients with albumin quotient (qalb) > (4 + age/15) x 10(-3) were assigned to the qalb increased (high BBB permeability) group (33%) and the remainder to the qalb normal group. Compared to the qalb normal group, the qalb increased group exhibited significantly lower serum albumin (P=0.001) and CD4+ T cell count (P=0.044), CD8+ T cell count (P=0.014), and total T lymphocyte count (P=0.016). The qalb increased group proved higher CSF albumin, total protein, leukocyte count, and IgG titer (all P=0.000). Optic neuritis and optic nerve abnormalities on magnetic resonance images were also more frequent in the qalb increased group (P=0.037 and 0.038, respectively). Patients in the qalb increased group showed significantly poorer treatment response as indicated by the lower post-treatment change in Expanded Disability Status Scale (EDSS) score compared to the qalb normal group. Conclusions: BBB permeability is strongly associated with the clinical features and treatment response of newly diagnosed NMOSD. The qalb is a potentially valuable indicator of disease severity and an index to guide personalized treatment.
引用
收藏
页码:324 / 330
页数:7
相关论文
共 50 条
  • [21] Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review
    Anamnart, Chumpol
    Tisavipat, Nanthaya
    Owattanapanich, Weerapat
    Apiwattanakul, Metha
    Savangned, Pakawee
    Prayoonwiwat, Naraporn
    Siritho, Sasitorn
    Rattanathamsakul, Natthapon
    Jitprapaikulsan, Jiraporn
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [22] Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption
    Uchida, Tomohiko
    Mori, Masahiro
    Uzawa, Akiyuki
    Masuda, Hiroki
    Muto, Mayumi
    Ohtani, Ryohei
    Kuwabara, Satoshi
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (08) : 1072 - 1084
  • [23] Blood Brain Barrier Permeability Could Be a Biomarker to Predict Severity of Neuromyelitis Optica Spectrum Disorders: A Retrospective Analysis
    Wang, Ying
    Zhu, Mingqin
    Liu, Caiyun
    Han, Jinming
    Lang, Wenjuan
    Gao, Yang
    Lu, Chao
    Wang, Shuang
    Hou, Shuai
    Zheng, Nannan
    Wang, Dong
    Chen, Yang
    Zhang, Yu
    Zhang, Hong-Liang
    Zhu, Jie
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [24] Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study
    Pache, F.
    Zimmermann, H.
    Finke, C.
    Lacheta, A.
    Papazoglou, S.
    Kuchling, J.
    Wuerfel, J.
    Hamm, B.
    Ruprecht, K.
    Paul, F.
    Brandt, A. U.
    Scheel, M.
    EUROPEAN RADIOLOGY, 2016, 26 (12) : 4413 - 4422
  • [25] Imaging Transcriptomics of Brain Functional Alterations in MS and Neuromyelitis Optica Spectrum Disorder
    Li, Yuna
    Sun, Jun
    Zhuo, Zhizheng
    Guo, Min
    Duan, Yunyun
    Xu, Xiaolu
    Tian, Decai
    Li, Kuncheng
    Zhou, Fuqing
    Li, Haiqing
    Zhang, Ningnannan
    Han, Xuemei
    Shi, Fudong
    Li, Yongmei
    Zhang, Xinghu
    Liu, Yaou
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2024, 45 (12) : 1901 - 1909
  • [26] Paroxysmal symptoms in neuromyelitis optica spectrum disorder: Results from an online patient survey
    Lotan, Itay
    Bacon, Tamar
    Kister, Ilya
    Levy, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [27] Relationship between blood-brain permeability and antibodies against aquaporins in neuromyelitis optica spectrum disorders and multiple sclerosis patients
    Jasiak-Zatonska, Michalina
    Michalak, Slawomir
    Osztynowicz, Krystyna
    Kozubski, Wojciech
    Kalinowska-Lyszczarz, Alicja
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2022, 56 (04) : 308 - 317
  • [28] Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of lifef
    Seok, Jin Myoung
    Choi, Misong
    Cho, Eun Bin
    Lee, Hye Lim
    Kim, Byoung Joon
    Lee, Kwang Ho
    Song, Pamela
    Joo, Eun Yeon
    Min, Ju-Hong
    PLOS ONE, 2017, 12 (05):
  • [29] Mechanical disruption of the blood-brain barrier following experimental concussion
    Johnson, Victoria E.
    Weber, Maura T.
    Xiao, Rui
    Cullen, D. Kacy
    Meaney, David F.
    Stewart, William
    Smith, Douglas H.
    ACTA NEUROPATHOLOGICA, 2018, 135 (05) : 711 - 726
  • [30] Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
    Waubant, Ernmanuelle
    DISEASE MARKERS, 2006, 22 (04) : 235 - 244